Refining Clinical Risk Stratification for Predicting Stroke and Thromboembolism in Atrial Fibrillation Using a Novel Risk Factor-Based Approach
Open accessThe DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Contemporary clinical risk stratification schemata for predicting stroke and thromboembolism (TE) in patients with atrial fibrillation (AF) are largely derived from risk factors identified from trial cohorts. Thus, many potential risk factors have not been included. METHODS: We refined the 2006 Birmingham/National Institute for Health and Clinical Excellence (NICE) stroke risk stratification schema into a risk factor-based approach by reclassifying and/or incorporating additional new risk factors where relevant. This schema was then compared with existing stroke risk stratification schema in a real-world cohort of patients with AF (n = 1,084) from the Euro Heart Survey for AF. RESULTS: Risk categorization differed widely between the different schemes compared. Patients classified as high risk ranged from 10.2% with the Framingham schema to 75.7% with the Birmingham 2009 schema. The classic CHADS(2) (Congestive heart failure, Hypertension, Age > 75, Diabetes, prior Stroke/transient ischemic attack) schema categorized the largest proportion (61.9%) into the intermediate-risk strata, whereas the Birmingham 2009 schema classified 15.1% into this category. The Birmingham 2009 schema classified only 9.2% as low risk, whereas the Framingham scheme categorized 48.3% as low risk. Calculated C-statistics suggested modest predictive value of all schema for TE. The Birmingham 2009 schema fared marginally better (C-statistic, 0.606) than CHADS(2). However, those classified as low risk by the Birmingham 2009 and NICE schema were truly low risk with no TE events recorded, whereas TE events occurred in 1.4% of low-risk CHADS(2) subjects. When expressed as a scoring system, the Birmingham 2009 schema (CHA(2)DS(2)-VASc acronym) showed an increase in TE rate with increasing scores (P value for trend = .003). CONCLUSIONS: Our novel, simple stroke risk stratification schema, based on a risk factor approach, provides some improvement in predictive value for TE over the CHADS(2) schema, with low event rates in low-risk subjects and the classification of only a small proportion of subjects into the intermediate-risk category. This schema could improve our approach to stroke risk stratification in patients with AF.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“However, diabetes may not be a significant risk factor for stroke in the elderly.620”
From 2023 ESC guidelines for the management of cardiovascular disease in patients with diabetes. (2023) · cites this paper as [620]
Experimental — accuracy not yet measuredIn the citing paper
“while patients with stroke risk factors (i.e.CHA 2 DS 2 -VASc score of 1 or more for men, and 2 or more for women) are likely to benefit from OAC.”
From 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS (2016) · cites this paper as [368]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Collaboration, A. T. (2002) · BMJ · doi:10.1136/bmj.324.7329.71 · Cited by 6,943
Hart, R. G., Pearce, L. A., & Aguilar, M. I. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-146-12-200706190-00007 · Cited by 4,793
(1994) · Archives of Internal Medicine · doi:10.1001/archinte.1994.00420130036007 · Cited by 2,071
Mant, J., Hobbs, F. R., Fletcher, K., Roalfe, A., Fitzmaurice, D., Lip, G. Y., & Murray, E. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61233-1 · Cited by 1,556
Self-citationBelch, J., MacCuish, A., Campbell, I., Cobbe, S., Taylor, R., Prescott, R., Lee, R., Bancroft, J., MacEwan, S., Shepherd, J., et al. (2008) · BMJ · doi:10.1136/bmj.a1840 · Cited by 977
Connolly, S. J., Pogue, J., Eikelboom, J., Flaker, G., Commerford, P., Franzosi, M. G., Healey, J. S., & Yusuf, S. (2008) · Circulation · doi:10.1161/circulationaha.107.750000 · Cited by 870
Wang, T. J., Massaro, J. M., Levy, D., Vasan, R. S., Wolf, P. A., D'Agostino, R. B., Larson, M. G., Kannel, W. B., & Benjamin, E. J. (2003) · JAMA · doi:10.1001/jama.290.8.1049 · Cited by 780
Antithrombotic Therapy in Atrial Fibrillation
Singer, D. E., Albers, G. W., Dalen, J. E., Fang, M. C., Go, A. S., Halperin, J. L., Lip, G. Y. H., & Manning, W. J. (2008) · Chest · doi:10.1378/chest.08-0678 · Cited by 751
Self-citationGage, B. F., van Walraven, C., Pearce, L., Hart, R. G., Koudstaal, P. J., Boode, B. S. P., & Petersen, P. (2004) · Circulation · doi:10.1161/01.cir.0000145172.55640.93 · Cited by 749
Cited by
Items 401–500 of 1,020
Bleeding Outcomes After Left Atrial Appendage Closure Compared With Long-Term Warfarin
Price, M. J., Reddy, V. Y., Valderrábano, M., Halperin, J. L., Gibson, D. N., Gordon, N. T., Huber, K. C., & Holmes, D. R. (2015) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2015.08.035 · Cited by 125
Aspberg, S., Chang, Y., Atterman, A., Bottai, M., Go, A. S., & Singer, D. E. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw077 · Cited by 125
Edoxaban in Asian Patients With Atrial Fibrillation
Lee, S., Choi, E., Han, K., Jung, J., Oh, S., & Lip, G. Y. H. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.05.066 · Cited by 125
Self-citationHopkins, B. S., Mazmudar, A. S., Driscoll, C., Svet, M. T., Goergen, J. A., Kelsten, M. F., Shlobin, N. A., Kesavabhotla, K., Smith, Z. A., & Dahdaleh, N. S. (2020) · Clinical Neurology and Neurosurgery · doi:10.1016/j.clineuro.2020.105718 · Cited by 124
Holt, A., Gislason, G. H., Schou, M., Zareini, B., Biering-Sørensen, T., Phelps, M., Kragholm, K., Andersson, C., Fosbøl, E. L., Hansen, M. L., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehaa494 · Cited by 111
Wallace, E., Dillon, C., Dimitrov, B. D., Fahey, T. P., & Keogh, C. (2011) · Thrombosis and Haemostasis · doi:10.1160/th11-02-0061 · Cited by 123
Chao, T., Liu, C., Liao, J., Wang, K.-L., Lin, Y., Chang, S., Lo, L., Hu, Y., Tuan, T., Chung, F., et al. (2016) · Circulation · doi:10.1161/circulationaha.115.019794 · Cited by 123
Self-citationVolgman, A. S., Benjamin, E. J., Curtis, A. B., Fang, M. C., Lindley, K. J., Naccarelli, G. V., Pepine, C. J., Quesada, O., Vaseghi, M., Waldo, A. L., et al. (2020) · Journal of Cardiovascular Electrophysiology · doi:10.1111/jce.14838 · Cited by 123
Chua, S., Shyu, K., Lu, M.-J., Lien, L.-M., Lin, C., Chao, H., & Lo, H. (2013) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2013.03.040 · Cited by 123
Kornej, J., Hindricks, G., Kosiuk, J., Arya, A., Sommer, P., Husser, D., Rolf, S., Richter, S., Huo, Y., Piorkowski, C., et al. (2014) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.113.001182 · Cited by 123
Aldhoon, B., Wichterle, D., Peichl, P., Cihak, R. J., & Kautzner, J. (2012) · EP Europace · doi:10.1093/europace/eus304 · Cited by 122
Panikker, S., Jarman, J. W. E., Virmani, R., Kutys, R., Haldar, S., Lim, E., Butcher, C., Khan, H. R., Mantziari, L., Nicol, E. D., et al. (2016) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.115.003710 · Cited by 123
Application of Biomarkers for Risk Stratification in Patients with Atrial Fibrillation
Hijazi, Z., Oldgren, J., Siegbahn, A. G., & Wallentin, L. C. (2017) · Clinical Chemistry · doi:10.1373/clinchem.2016.255182 · Cited by 122
Perioperative management of patients on direct oral anticoagulants
Dubois, V., Dincq, A.-S., Douxfils, J., Ickx, B., Samama, C. M., Dogné, J., Gourdin, M. J., Châtelain, B., Mullier, F., & Lessire, S. (2017) · Thrombosis Journal · doi:10.1186/s12959-017-0137-1 · Cited by 122
Kuo, L., Chao, T., Liu, C., Lin, Y., Chang, S., Lo, L., Hu, Y., Tuan, T., Liao, J., Chung, F., et al. (2017) · Journal of the American Heart Association · doi:10.1161/jaha.116.005307 · Cited by 123
Self-citationBurden of Atrial Fibrillation–Associated Ischemic Stroke in the United States
Alkhouli, M. A., Alqahtani, F., Aljohani, S., Alvi, M., & Holmes, D. R. (2018) · JACC. Clinical electrophysiology · doi:10.1016/j.jacep.2018.02.021 · Cited by 122
Sudden Cardiac Death in Hypertrophic Cardiomyopathy
O’Mahony, C., Elliot, P. M., & McKenna, W. J. (2012) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.111.962043 · Cited by 124
van Diepen, S., Hellkamp, A. S., Patel, M. R., Becker, R. C., BREITHARDT, G. E., Hacke, W., Halperin, J. L., Hankey, G. J., Nessel, C. C., Singer, D. E., et al. (2013) · Circulation Heart Failure · doi:10.1161/circheartfailure.113.000212 · Cited by 121
Age Threshold for Increased Stroke Risk Among Patients With Atrial Fibrillation
Chao, T., Wang, K.-L., Liu, C.-J., Lin, Y., Chang, S., Lo, L., Hu, Y., Tuan, T., Chung, F., Liao, J., et al. (2015) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.07.026 · Cited by 121
Self-citationWilke, T., Bauer, S., Mueller, S., Kohlmann, T., & Bauersachs, R. M. (2016) · Patient · doi:10.1007/s40271-016-0185-9 · Cited by 123
Wessler, B. S., Lai YH, L., Kramer, W., Cangelosi, M., Raman, G., Lutz, J. S., & Kent, D. M. (2015) · Circulation: Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.115.001693 · Cited by 105
Lip, G. Y. H., Haguenoer, K., Saint-Etienne, C., & Fauchier, L. (2014) · Chest · doi:10.1378/chest.13-2976 · Cited by 120
Self-citationShared Decision-making in the Emergency Department: Respecting Patient Autonomy When Seconds Count
Hess, E. P., Grudzen, C. R., Thomson, R., Raja, A. S., & Carpenter, C. R. (2015) · Academic Emergency Medicine · doi:10.1111/acem.12703 · Cited by 120
Kefer, J., Tzikas, A., Freixa, X., Shakir, S., Gafoor, S. A., Nielsen‐Kudsk, J. E., Berti, S. L., Santoro, G., Aminian, A., Landmesser, U., et al. (2016) · International Journal of Cardiology · doi:10.1016/j.ijcard.2016.01.003 · Cited by 120
A frameshift deletion in the sarcomere gene MYL4 causes early-onset familial atrial fibrillation
Gudbjartsson, D. F., Holm, H., Sulem, P., Masson, G., Oddsson, A., Magnusson, O. T., Saemundsdottir, J., Helgadottir, H. T., Helgason, H., Johannsdottir, H., et al. (2017) · European Heart Journal · doi:10.1093/eurheartj/ehw379 · Cited by 117
Intracardiac Versus Transesophageal Echocardiographic Guidance for Left Atrial Appendage Occlusion
Berti, S. L., Pastormerlo, L. E., Santoro, G., Brscic, E., Montorfano, M., Vignali, L., Danna, P., Tondo, C., Rezzaghi, M., D’Amico, G., et al. (2018) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2018.05.008 · Cited by 120
Li, Y., Bisson, A., Bodin, A., Herbert, J., Grammatico‐Guillon, L., Joung, B., Wang, Y., Lip, G. Y. H., & Fauchier, L. (2019) · Journal of the American Heart Association · doi:10.1161/jaha.119.012546 · Cited by 120
Self-citationGolwala, H., Jackson, L. R., Simon, D. N., Piccini, J. P., Gersh, B., Go, A. S., Hylek, E. M., Kowey, P. R., Mahaffey, K. W., Thomas, L., et al. (2016) · American Heart Journal · doi:10.1016/j.ahj.2015.10.028 · Cited by 113
Chao, T.-F., Lip, G. Y. H., Liu, C.-J., Tuan, T.-C., Chen, S.-J., Wang, K.-L., Lin, Y.-J., Chang, S.-L., Lo, L.-W., Hu, Y.-F., et al. (2016) · Stroke · doi:10.1161/strokeaha.116.013880 · Cited by 105
Self-citationYoon, M., Yang, P., Jang, E., Yu, H. J., Kim, T., Uhm, J., Kim, J., Pak, H., Lee, M., Lip, G. Y. H., et al. (2018) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1651482 · Cited by 120
Self-citationEHRA/EAPCI expert consensus statement on catheter-based left atrial appendage occlusion
Meier, B., Blaauw, Y., Khattab, A. A., Lewalter, T., Sievert, H., Tondo, C., & Glikson, M. (2015) · EuroIntervention · doi:10.4244/eijy14m09_18 · Cited by 119
An Integrated Management Approach to Atrial Fibrillation
Carter, L., Gardner, M., Magee, K., Fearon, A., Morgulis, I., Doucette, S., Sapp, J. L., Gray, C., Abdelwahab, A., & Parkash, R. (2016) · Journal of the American Heart Association · doi:10.1161/jaha.115.002950 · Cited by 118
Roldán, V., Marín, F. R., DÍAZ, J., Gallego, P., Jover, E., Romera, M., Manzano‐Fernández, S., Casas, T., Valdés, M., Vicente, V., et al. (2012) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2012.04812.x · Cited by 118
Self-citationPractical Management of Anticoagulation in Patients With Atrial Fibrillation
Kovacs, R. J., Flaker, G. C., Saxonhouse, S. J., Doherty, J. U., Birtcher, K. K., Cuker, A. C., Davidson, B. L., Giugliano, R. P., Granger, C. B., Jaffer, A. K., et al. (2015) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.01.049 · Cited by 118
Okumura, K., Inoue, H., Atarashi, H., Yamashita, T., Tomita, H., Origasa, H., & for the J-RHYTHM Registry Investigators. (2014) · Circulation Journal · doi:10.1253/circj.cj-14-0144 · Cited by 118
Performance and Validation of a Novel Biomarker-Based Stroke Risk Score for Atrial Fibrillation
Oldgren, J., Hijazi, Z., Lindbäck, J., Alexander, J. H., Connolly, S. J., Eikelboom, J. W., Ezekowitz, M. D., Granger, C. B., Hylek, E. M., Lopes, R. D., et al. (2016) · Circulation · doi:10.1161/circulationaha.116.022802 · Cited by 104
Genetic Risk Prediction of Atrial Fibrillation
Lubitz, S. A., Yin, X., Lin, H. J., Kolek, M., Smith, J. G., Trompet, S., Rienstra, M., Rost, N. S., Teixeira, P. L., Almgren, P., et al. (2017) · Circulation · doi:10.1161/circulationaha.116.024143 · Cited by 113
SCAI/HRS Expert Consensus Statement on Transcatheter Left Atrial Appendage Closure
Saw, J., Holmes, D. R., Cavalcante, J. L., Freeman, J. V., Goldsweig, A. M., Kavinsky, C. J., Moussa, I. D., Munger, T. M., Price, M. J., Reisman, M., et al. (2023) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2023.01.011 · Cited by 118
Douketis, J. D. (2011) · Blood · doi:10.1182/blood-2011-02-329979 · Cited by 119
Christersson, C., Wallentin, L. C., Andersson, U., Alexander, J. H., Ansell, J., Caterina, R. D., Gersh, B. J., Granger, C. B., Hanna, M., Horowitz, J. D., et al. (2014) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.12638 · Cited by 118
Potpara, T. S., Polovina, M. M., Licina, M. M., Marinkovic, J. M., Prostran, M. S., & Lip, G. Y. H. (2012) · Circulation: Arrhythmia and Electrophysiology · doi:10.1161/circep.111.966713 · Cited by 102
Self-citationZhan, Y., Joza, J. E., Rawahi, M. A., Barbosa, R. S., Samuel, M., Bernier, M., Huynh, T. T., Thanassoulis, G., & Essebag, V. (2017) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2017.12.008 · Cited by 117
Seiffge, D. J., Paciaroni, M., Wilson, D., Koga, M., Macha, K., Cappellari, M., Schaedelin, S. A., Shakeshaft, C., Takagi, M., Tsivgoulis, G. K., et al. (2019) · Annals of Neurology · doi:10.1002/ana.25489 · Cited by 118
Polypharmacy and major adverse events in atrial fibrillation: observations from the AFFIRM trial
Proietti, M., Raparelli, V., Olshansky, B., & Lip, G. Y. H. (2015) · Clinical Research in Cardiology · doi:10.1007/s00392-015-0936-y · Cited by 117
Self-citationScheitz, J. F., Erdur, H., Haeusler, K. G., Audebert, H. J., Roser, M., Laufs, U., Endres, M., & Nolte, C. H. (2015) · Stroke · doi:10.1161/strokeaha.115.008681 · Cited by 102
Female sex as an independent risk factor for stroke in atrial fibrillation: Possible mechanisms
Albert, C. M., Andreotti, F., Badimon, L., Van Gelder, I. C., Hylek, E. M., & Cove, C. L. (2014) · Thrombosis and Haemostasis · doi:10.1160/th13-04-0347 · Cited by 116
Roldán, V., Marín, F. R., Manzano‐Fernández, S., Fernández, H., Gallego, P., Valdés, M., Vicente, V., & Lip, G. Y. H. (2013) · Thrombosis and Haemostasis · doi:10.1160/th13-01-0054 · Cited by 118
Self-citationAtrial fibrillation patients do not benefit from acetylsalicylic acid
Sjalander, S., Sjalander, A., Svensson, P. J., & Friberg, L. (2014) · Europace · doi:10.1093/europace/eut333 · Cited by 95
Andrade, J. G., Macle, L., Nattel, S., Verma, A., & Cairns, J. A. (2017) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2017.06.002 · Cited by 116
Less dementia and stroke in low-risk patients with atrial fibrillation taking oral anticoagulation
Friberg, L., Andersson, T., & Rosenqvist, M. (2019) · European Heart Journal · doi:10.1093/eurheartj/ehz304 · Cited by 115
Lip, G. Y. H., Coca, A., Kahan, T., Boriani, G., Manolis, A. S., Olsen, M. H., Oto, A., Potpara, T., Steffel, J., Marín, F. R., et al. (2017) · European Heart Journal - Cardiovascular Pharmacotherapy · doi:10.1093/ehjcvp/pvx019 · Cited by 119
Self-citationD’Souza, M., Carlson, N., Fosbøl, E. L., Lamberts, M., Smedegaard, L., Nielsen, D. L., Torp-Pedersen, C. T., Gislason, G., & Schou, M. (2018) · European Journal of Preventive Cardiology · doi:10.1177/2047487318759858 · Cited by 114
Kanwal, F., Taylor, T. J., Kramer, J. R., Cao, Y., Smith, D. L., Gifford, A. L., El‐Serag, H. B., Naik, A. D., & Asch, S. M. (2020) · JAMA Network Open · doi:10.1001/jamanetworkopen.2020.23780 · Cited by 114
Anticoagulation in atrial fibrillation
Steinberg, B. A., & Piccini, J. P. (2014) · BMJ · doi:10.1136/bmj.g2116 · Cited by 114
Steinberg, B. A., Holmes, D. N., Piccini, J. P., Ansell, J., Chang, P., Fonarow, G. C., Gersh, B. J., Mahaffey, K. W., Kowey, P. R., Ezekowitz, M. D., et al. (2013) · Journal of the American Heart Association · doi:10.1161/jaha.113.000535 · Cited by 113
Bouillon, K., Bertrand, M., Maura, G., Blotière, P., Ricordeau, P., & Zureik, M. (2015) · The Lancet Haematology · doi:10.1016/s2352-3026(15)00027-7 · Cited by 113
Xu, H., Ruff, C. T., Giugliano, R. P., Murphy, S. A., Nordio, F., Patel, I. J., Shi, M., Mercuri, M. F., Antman, E. M., & Braunwald, E. (2016) · Journal of the American Heart Association · doi:10.1161/jaha.115.002587 · Cited by 113
Görenek, B., Pelliccia, A., Benjamin, E. J., Boriani, G., Crijns, H. J. G. M., Fogel, R. I., Gelder, I. C. V., Halle, M., Kudaiberdieva, G., Lane, D. A., et al. (2017) · European Journal of Preventive Cardiology · doi:10.1177/2047487316676037 · Cited by 116
Self-citationPopulation-Based Screening for Atrial Fibrillation
Khurshid, S., Healey, J. S., McIntyre, W. F., & Lubitz, S. A. (2020) · Circulation Research · doi:10.1161/circresaha.120.316341 · Cited by 101
Vernooij, L. M., van Klei, W. A., Moons, K. G. M., Takada, T., van Waes, J. A. R., & Damen, J. A. (2021) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013139.pub2 · Cited by 113
Poli, S., Diedler, J., Härtig, F., Götz, N., Bauer, A., Sachse, T., Müller, K., Müller, I. I., Stimpfle, F., Duckheim, M., et al. (2015) · European Journal of Neurology · doi:10.1111/ene.12843 · Cited by 112
Zhu, J. S., Ge, P., Jiang, C., Zhang, Y., Li, X., Zhao, Z., Zhang, L., & Duong, T. Q. (2020) · JACEP Open · doi:10.1002/emp2.12205 · Cited by 97
Secondary stroke prevention in people with atrial fibrillation: treatments and trials
Seiffge, D. J., Cancelloni, V., Räber, L., Paciaroni, M., Metzner, A., Kirchhof, P. F., Fischer, U., Werring, D. J., Shoamanesh, A., & Caso, V. (2024) · The Lancet Neurology · doi:10.1016/s1474-4422(24)00037-1 · Cited by 112
Toyoda, Ḱ., Arihiro, S., Todo, K., Yamagami, H., Kimura, K., Furui, E., Terasaki, T., Shiokawa, Y., Kamiyama, K., Takizawa, S., et al. (2015) · International Journal of Stroke · doi:10.1111/ijs.12452 · Cited by 113
Rao, M. P., Halvorsen, S., Wojdyla, D., Thomas, L., Alexander, J. H., Hylek, E. M., Hanna, M., Bahit, M. C., Lopes, R. D., De Caterina, R., et al. (2015) · Journal of the American Heart Association · doi:10.1161/jaha.115.002015 · Cited by 101
Direct‐acting oral anticoagulants: pharmacology, indications, management, and future perspectives
Gómez‐Outes, A., Suárez‐Gea, M. L., Lecumberri, R., Terleira‐Fernández, A. I., & Vargas, E. (2015) · European Journal Of Haematology · doi:10.1111/ejh.12610 · Cited by 112
Liao, J., Chao, T., Liu, C., Wang, K.-L., Chen, S., Tuan, T.-C., Lin, Y.-J., Chang, S., Lo, L.-W., Hu, Y.-F., et al. (2015) · International Journal of Cardiology · doi:10.1016/j.ijcard.2015.06.170 · Cited by 111
Self-citationChristophersen, I. E., Yin, X., Larson, M. G., Lubitz, S. A., Magnani, J. W., McManus, D. D., Ellinor, P. T., & Benjamin, E. J. (2016) · American Heart Journal · doi:10.1016/j.ahj.2016.05.004 · Cited by 112
Ischemic Stroke Risk in Patients With Nonvalvular Atrial Fibrillation
Alkhouli, M., & Friedman, P. A. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.10.040 · Cited by 102
Himmelreich, J. C. L., Veelers, L., Lucassen, W. A. M., Schnabel, R. B., Rienstra, M., van Weert, H. C. P. M., & Harskamp, R. E. (2020) · EP Europace · doi:10.1093/europace/euaa005 · Cited by 110
Boriani, G., Vitolo, M., Diemberger, I., Proietti, M., Valenti, A. C., Malavasi, V. L., & Lip, G. Y. H. (2021) · Cardiovascular Research · doi:10.1093/cvr/cvab147 · Cited by 111
Self-citationKim, T., Yang, P., Uhm, J., Kim, J., Pak, H., Lee, M., Joung, B., & Lip, G. Y. H. (2017) · Stroke · doi:10.1161/strokeaha.117.016926 · Cited by 109
Self-citationMazurek, M., Huisman, M. V., Rothman, K. J., Paquette, M., Teutsch, C., Diener, H., Dubner, S., Halperin, J. L., Ma, C., Zint, K., et al. (2017) · Thrombosis and Haemostasis · doi:10.1160/th17-08-0555 · Cited by 109
Self-citationHeijman, J., Sutanto, H., Crijns, H. J. G. M., Nattel, S., & Trayanova, N. A. (2021) · Cardiovascular Research · doi:10.1093/cvr/cvab138 · Cited by 109
Self-citationÇetın, M., Çakıcı, M., Zencır, C., Taşolar, H., Baysal, E., Ballı, M., & Aktürk, E. (2013) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2013.11.056 · Cited by 110
Postoperative Atrial Fibrillation
Yadava, M., Hughey, A. B., & Crawford, T. C. (2016) · Heart Failure Clinics · doi:10.1016/j.hfc.2015.08.023 · Cited by 109
Nielsen, P. B., Larsen, T. B., Skjøth, F., Overvad, T. F., & Lip, G. Y. H. (2016) · Scientific Reports · doi:10.1038/srep27410 · Cited by 100
Self-citationGamra, H., Murín, J., Chiang, C., Naditch‐Brûlé, L., Brette, S., & Steg, P. G. (2014) · Archives of cardiovascular diseases · doi:10.1016/j.acvd.2014.01.001 · Cited by 108
Welles, C. C., Whooley, M. A., Na, B., Ganz, P., Schiller, N. B., & Turakhia, M. P. (2011) · American Heart Journal · doi:10.1016/j.ahj.2011.05.023 · Cited by 108
Scowcroft, A., Lee, S., & Mant, J. (2012) · Heart · doi:10.1136/heartjnl-2012-302843 · Cited by 108
Atrial Fibrillation Associated with Heart Failure, Stroke and Mortality.
Bordignon, S., Corti, M. C., & Bilato, C. (2012) · Europe PMC (PubMed Central) · doi:10.4022/jafib.467 · Cited by 108
Siddiqi, T. J., Usman, M., Shahid, I., Ahmed, J., Khan, S. U., Ya’qoub, L., Rihal, C. S., & Alkhouli, M. A. (2021) · European Journal of Preventive Cardiology · doi:10.1093/eurjpc/zwab018 · Cited by 109
World Heart Federation Roadmap on Atrial Fibrillation – A 2020 Update
Freedman, B., Hindricks, G., Banerjee, A., Baranchuk, A. M., Ching, C. K., Du, X., Fitzsimons, D., Healey, J. S., Ikeda, T., Lobban, T., et al. (2021) · Global Heart · doi:10.5334/gh.1023 · Cited by 108
AHEAD score — Long-term risk classification in acute heart failure
Špinar, J., Jarkovský, J., Špinarová, L., Mebazaa, A., Gayat, É., Vítovec, J., Linhart, A., Widimský, P., Miklík, R., Zeman, K., et al. (2015) · International Journal of Cardiology · doi:10.1016/j.ijcard.2015.08.187 · Cited by 107
Guha, D., Coyne, S., & Macdonald, R. L. (2015) · Journal of neurosurgery · doi:10.3171/2015.2.jns141889 · Cited by 107
Douketis, J. D., Spyropoulos, A. C., Anderson, J., Arnold, D. M., Bates, S. M., Blostein, M. D., Carrier, M., Caprini, J. A., Clark, N. P., Coppens, M., et al. (2017) · Thrombosis and Haemostasis · doi:10.1160/th17-08-0553 · Cited by 107
Escobar‐Robledo, L. A., Bayés‐Genís, A., Lupón, J., Baranchuk, A. M., Moliner, P., Martínez‐Sellés, M., Zamora, E., de Antonio, M., Domingo, M., Cediel, G., et al. (2018) · International Journal of Cardiology · doi:10.1016/j.ijcard.2018.05.050 · Cited by 107
Maheshwari, A., Norby, F. L., Roetker, N. S., Soliman, E. Z., Koene, R. J., Rooney, M. R., O’Neal, W. T., Shah, A. M., Claggett, B. L., Solomon, S. D., et al. (2019) · Circulation · doi:10.1161/circulationaha.118.035411 · Cited by 108
Demystifying artificial intelligence in pharmacy
Nelson, S. D., Walsh, C. G., Olsen, C. A., McLaughlin, A. J., LeGrand, J. R., Schutz, N., & Lasko, T. A. (2020) · American Journal of Health-System Pharmacy · doi:10.1093/ajhp/zxaa218 · Cited by 86
Chung, S., Sofat, R., Acosta, D., Taylor, J., Lambiase, P. D., Casas, J. P., & Providencia, R. A. (2021) · The Lancet Regional Health - Europe · doi:10.1016/j.lanepe.2021.100157 · Cited by 108
Jacobs, V., May, H. T., Bair, T. L., Crandall, B. G., Cutler, M. J., Day, J. D., Weiss, J. P., Osborn, J. S., Muhlestein, J. B., Anderson, J. L., et al. (2014) · Heart Rhythm · doi:10.1016/j.hrthm.2014.12.034 · Cited by 109
Vinson, D. R., Mark, D. G., Chettipally, U. K., Huang, J., Rauchwerger, A. S., Reed, M. E., Lin, J. S., Kene, M. V., Wang, D. H., Sax, D. R., et al. (2018) · Annals of Internal Medicine · doi:10.7326/m18-1206 · Cited by 97
Letsas, Κ. P., Efremidis, M., Γιαννόπουλος, Γ., Deftereos, S. G., Lioni, L., Korantzopoulos, P. G., Vlachos, K. G., Xydonas, S., Kossyvakis, C., & Sideris, A. (2013) · EP Europace · doi:10.1093/europace/eut210 · Cited by 106
Ball, J., Carrington, M. J., Stewart, S., & on behalf of the SAFETY investigators (2013) · Heart · doi:10.1136/heartjnl-2012-303182 · Cited by 89
Vergara, P., Tzou, W. S., Tung, R. H., Brombin, C., Nonis, A., Vaseghi, M., Frankel, D. S., Biase, L. D., Tedrow, U. B., Mathuria, N. S., et al. (2018) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.118.006730 · Cited by 106
Stroke in atrial fibrillation: epidemiology and thromboprophylaxis
Lip, G. Y. H. (2011) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2011.04302.x · Cited by 108
Self-citationTime to Cost-Effectiveness Following Stroke Reduction Strategies in AF
Reddy, V. Y., Akehurst, R. L., Armstrong, S. O., Amorosi, S. L., Beard, S. M., & Holmes, D. R. (2015) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.09.084 · Cited by 106
Atrial Fibrillation in Older People: Concepts and Controversies
Zathar, Z., Karunatilleke, A., Fawzy, A. M., & Lip, G. Y. H. (2019) · Frontiers in Medicine · doi:10.3389/fmed.2019.00175 · Cited by 105
Self-citationLong-Term Relationship Between Atrial Fibrillation, Multimorbidity and Oral Anticoagulant Drug Use
Proietti, M., Marzona, I., Vannini, T., Tettamanti, M., Fortino, I., Merlino, L. G., Basili, S., Mannucci, P. M., Boriani, G., Lip, G. Y. H., et al. (2019) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2019.06.012 · Cited by 105
Self-citationIngason, A. B., Hreinsson, J. P., Agustsson, A. S., Lund, S. H., Rumba, E., Pálsson, D. A., Reynisson, I. E., Guðmundsdóttir, B. R., Onundarson, P. T., & Bjornsson, E. S. (2021) · Annals of Internal Medicine · doi:10.7326/m21-1474 · Cited by 105
Metadata
- Authors
- Lip, G. Y. H., Nieuwlaat, R., Pisters, R., Lane, D. A., & Crijns, H. J. G. M.
- Affiliations
- Birmingham City Hospital (GB)
- Maastricht University Medical Centre (NL)
- Corresponding author
- Lip, Gregory Y.H.
- Venue
- Chest
- Publisher
- Elsevier BV
- Published
- 2010-02
- Volume
- 137
- Issue
- 2
- Pages
- 263-272
- ISSN
- 0012-3692 (ISSN-L)
- OpenAlex
- W2162586165
- Cited by
- 6,879
- References
- 34
- Citations by year
- 2026: 276 · 2025: 362 · 2024: 419 · 2023: 466 · 2022: 524 · 2021: 590 · 2020: 538 · 2019: 476 · 2018: 507 · 2017: 471 · 2016: 495 · 2015: 474 · 2014: 400 · 2013: 337 · 2012: 304
- FWCI
- 115.14
- Type
- journal article
- Language
- en
- Open access
- Licence
- other-oa
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Locations
- CHEST Journal (publishedVersion)
- PubMed (publishedVersion)
- Research Publications (Maastricht University) (publishedVersion, other-oa)
- Nova Science Publishers (Nova Science Publishers, Inc.) (submittedVersion)
- University of Birmingham Research Portal (University of Birmingham) (submittedVersion)
- Research Publications (Maastricht University) (submittedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Atrial Fibrillation Management and Outcomes
- Health Sciences › Medicine › Clinical Neurology › Acute Ischemic Stroke Management
- Health Sciences › Medicine › Internal Medicine › Venous Thromboembolism Diagnosis and Management
- Keywords
- atrial fibrillation, stroke risk stratification, thromboembolism, CHA2DS2-VASc score, CHADS2 score, risk prediction, risk reclassification
- MeSH terms
- Aged, Atrial Fibrillation, Europe, Female, Follow-Up Studies, Humans, Male, Population Surveillance, Prognosis, Retrospective Studies, Risk Factors, Thromboembolism, Reproducibility of Results, Incidence, Risk Assessment, Stroke
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.